Kamada (KMDA) reported $180M in revenue for fiscal 2025, +12.1% year on year. That ranks #2702 by revenue among 2853 SEC filers and #294 in Healthcare. Net income was $20.2M, a net margin of 11.2%. Revenue has grown 9.9% a year on average since 2015 ($69.9M then). The fiscal 2025 balance sheet shows $379M in total assets, $75.5M in cash and $17.4M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenue | $180M | +12.1% | FY20252025-12-31 |
| Gross profitGrossProfit | $76.4M | +9.2% | FY20252025-12-31 |
| Operating incomeProfitLossFromOperatingActivities | $26.2M | +30.8% | FY20252025-12-31 |
| Net incomeProfitLoss | $20.2M | +39.7% | FY20252025-12-31 |
| Operating cash flowCashFlowsFromUsedInOperatingActivities | $25.5M | −46.4% | FY20252025-12-31 |
| Capital expenditure | Not reported | — | |
| Total assetsAssets | $379M | +1.7% | FY20252025-12-31 |
| Shareholders' equityEquity | $269M | +3.7% | FY20252025-12-31 |
| CashCashAndCashEquivalents | $75.5M | −3.8% | FY20252025-12-31 |
| Long-term debtLongtermBorrowings | $17.4M | −13.1% | FY20222022-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Figures are reported under IFRS, in US dollars.
Profile
- Legal name
- Kamada LTD
- Ticker
- KMDA
- Exchange
- Nasdaq
- SIC classification
- Pharmaceutical Preparations (2834)
- Fiscal year end
- 12-31
- CIK
- 0001567529
Filings
- 20-FMar 11, 2026Open filing →
- 20-FMar 5, 2025Open filing →
- 20-FMar 6, 2024Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Maravai LifesciencesMRVI | $186M | −$131M |
| Stoke TherapeuticsSTOK | $184M | −$6.9M |
| Glass House BrandsGLAS | $182M | −$29.7M |
| KamadaKMDA | $180M | $20.2M |
| Petmed ExpressPETS | $179M | −$57.3M |
| CryoportCYRX | $176M | $78.3M |
| HeartflowHTFL | $176M | −$117M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Kamada — Key figures |url=https://companiesranked.com/en/company/kamada |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Kamada — Key figures. CompaniesRanked. https://companiesranked.com/en/company/kamadaBibTeX
@misc{companiesranked-en-company-kamada-2026,
author = {{CompaniesRanked}},
title = {{Kamada — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/kamada}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001213900-26-025934 · March 11, 2026
{{cite web |title=Kamada — Key figures — 20-F (0001213900-26-025934) |url=https://www.sec.gov/Archives/edgar/data/1567529/000121390026025934/ea0276358-20f_kamada.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-11}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.